Direxion Daily S&P Biotech Bull 3X Shares (LABU): Price and Financial Metrics ETF
LABU Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $90.09 | 52-week high | $176.99 |
| Prev. close | $89.66 | 52-week low | $78.46 |
| Day low | $89.41 | Volume | 710,927 |
| Day high | $92.42 | Avg. volume | 1,522,052 |
| 50-day MA | $106.25 | Dividend yield | 0.35% |
| 200-day MA | $116.59 |
LABU Stock Price Chart Interactive Chart >
Direxion Daily S&P Biotech Bull 3X Shares (LABU) ETF Bio
The investment objective of the Direxion Daily S&P Biotech Bull 3X ETF seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index.
LABU ETF Info
| Issuer | Direxion Investments |
| Expense Ratio | 1.01% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Portfolio-Multi Asset |
| Sector | Biotech |
| Assets Under Management (AUM) | 837.20K |
| Net Asset Value (NAV) | $89.79 |
| Options? | Yes |
| Total Holdings | 147 |
LABU Top Holdings
| Symbol | Company | % of Total |
| DREYFUS GOVT CASH MAN INS | 21.41% | |
| GOLDMAN FINL SQ TRSRY INST 506 | 16.36% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 9.47% | |
| DREYFUS TRSRY SECURITIES CASH MGMT | 4.98% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.99% |
| AMGN | AMGEN INC | 1.77% |
| GILD | GILEAD SCIENCES INC | 1.77% |
| INCY | INCYTE CORP | 1.77% |
| UTHR | UNITED THERAPEUTICS CORP | 1.77% |
| ABBV | ABBVIE INC | 1.75% |
LABU Price Returns
| 1-mo | -6.21% |
| 3-mo | -25.42% |
| 6-mo | -38.36% |
| 1-year | -24.12% |
| 3-year | -74.42% |
| 5-year | -90.70% |
| YTD | 0.10% |
| 2024 | -26.02% |
| 2023 | -12.63% |
| 2022 | -80.36% |
| 2021 | -64.15% |
| 2020 | 74.66% |
LABU Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||